Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.

Rubin D. T., Allegretti J. R., Panés J., Shipitofsky N., Yarandi S. S., Huang K. G., ...More

Lancet (London, England), 2024 (SCI-Expanded, Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2024
  • Doi Number: 10.1016/s0140-6736(24)01927-5
  • Journal Name: Lancet (London, England)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Abstracts in Social Gerontology, Aquatic Science & Fisheries Abstracts (ASFA), Artic & Antarctic Regions, BIOSIS, Business Source Elite, Business Source Premier, CAB Abstracts, CINAHL, Food Science & Technology Abstracts, Psycinfo, Public Affairs Index, Veterinary Science Database, Nature Index
  • Gazi University Affiliated: Yes

Abstract

Improvements in the exposition.